Chemosensitisation of drug-resistant and drug-sensitive yeast cells to antifungals

International Journal of Antimicrobial Agents

Volumn 29, Issue 2, 2007, Pages 170-178

  Cernicka, Jana ^a   Kozovska, Zuzana ^a   Hnatova, Martina ^a   Valachovic, Martin ^b   Hapala, Ivan ^b   Riedl, Zsuzsanna ^c   Hajós, György ^c   Subik, Julius ^a  

^a Physics and Informatics   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c CHEMICAL RESEARCH CENTER   (Hungary)

Author keywords

Antifungal agents; Candida albicans; Candida glabrata; Chemosensitiser; Drug resistance; Saccharomyces cerevisiae; Yeast

Indexed keywords

7 CHLOROTETRAZOLO[5,1 C]BENZO[1,2,4]TRIAZINE; ANTIFUNGAL AGENT; TRANSCRIPTION FACTOR PDR1P; TRANSCRIPTION FACTOR PDR3P; TRANSCRIPTION FACTOR PDR5P; TRANSCRIPTION FACTOR SNQ2P; TRANSCRIPTION FACTOR YAP1P; TRIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CHEMOSENSITIZATION; DRUG MECHANISM; GENE MUTATION; GENE OVEREXPRESSION; KLUYVEROMYCES; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; YEAST CELL;

ANTIFUNGAL AGENTS; DRUG RESISTANCE, FUNGAL; MICROBIAL SENSITIVITY TESTS; RHODAMINES; SACCHAROMYCES CEREVISIAE; STEROLS; TRIAZINES;

EID: 33846117607     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.08.037     Document Type: Article

References (50)

1. In: Paulsen I.T., and Lewis K. (Eds). Microbial multidrug efflux (2002), Horizon Scientific Press, Norfolk, UK
2. Robert J. Multidrug resistance in oncology: diagnostic and therapeutic approaches. Eur J Clin Invest 29 (1999) 536-545
3. Kolaczkowska A., and Goffeau A. Regulation of pleiotropic drug resistance in yeast. Drug Resist Updat 2 (1999) 403-414
4. Prasad R., Panwar S.L., and Smriti. Drug resistance in yeasts-an emerging scenario. Adv Microb Physiol 46 (2002) 155-201
5. Decottignies A., and Goffeau A. Complete inventory of the yeast ABC proteins. Nat Genet 15 (1997) 137-145
6. Nellisen B., De Wachter R., and Goffeau A. Classification of all putative permeases and other membrane plurispanners of the major facilitator superfamily encoded by the complete genome of Saccharomyces cerevisiae. FEMS Microbiol Rev 21 (1997) 113-134
7. Moye-Rowley W.S. Transcriptional control of multidrug resistance in the yeast Saccharomyces. Prog Nucleic Acid Res Mol Biol 73 (2003) 251-279
8. Prasad R., De Wergifosse P., Goffeau A., and Balzi E. Molecular cloning and characterization of a novel gene of Candida albicans, CDR1, conferring multiple resistance to drugs and antifungals. Curr Genet 27 (1995) 320-329
9. Sanglard D., Ischer F., Monod M., and Bille J. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143 (1997) 405-416
10. Fling M.E., Kopf J., Tamarkin A., Gorman J.A., Smith H.A., and Koltin Y. Analysis of a Candida albicans gene that encodes a novel mechanism for resistance to benomyl and methotrexate. Mol Gen Genet 227 (1991) 318-329
11. Coste A.T., Karababa M., Ischer F., Bille J., and Sanglard D. TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2. Eukaryot Cell 3 (2004) 1639-1652
12. Nourani A., Papajova D., Delahodde A., Jacq C., and Subik J. Clustered amino acid substitutions in the yeast transcription regulator Pdr3p increase pleiotropic drug resistance and identify a new central regulatory domain. Mol Gen Genet 256 (1997) 397-405
13. Carvajal E., van den Hazel H.B., Cybularz-Kolaczkowska A., Balzi E., and Goffeau A. Molecular and phenotypic characterization of yeast PDR1 mutants that show hyperactive transcription of various ABC multidrug transporter genes. Mol Gen Genet 256 (1997) 406-415
14. Simonics T., Kozovska Z., Michalkova-Papajova D., Delahodde A., Jacq C., and Subik J. Isolation and molecular characterization of the carboxy-terminal pdr3 mutants in Saccharomyces cerevisiae. Curr Genet 38 (2000) 248-255
15. Delaveau T., Delahodde A., Carvajal E., Subik J., and Jacq C. PDR3, a new yeast regulatory gene, is homologous to PDR1 and controls the multidrug resistance phenomenon. Mol Gen Genet 244 (1994) 501-511
16. Onishi J., Meinz M., Thompson J., et al. Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors. Antimicrob Agents Chemother 44 (2000) 368-377
17. Di Pietro A., Conseil G., Perez-Victoria J.M., et al. Modulation by flavonoids of cell multidrug resistance mediated by P-glycoprotein and related ABC transporters. Cell Mol Life Sci 59 (2002) 307-322
18. Egner R., Bauer B.E., and Kuchler K. The transmembrane domain 10 of the yeast Pdr5p ABC antifungal efflux pump determines both substrate specificity and inhibitor susceptibility. Mol Microbiol 35 (2000) 1255-1263
19. Maesaki S., Marichal P., Hossain M.A., Sanglard D., Vanden Bossche H., and Kohno S. Synergic effects of tactolimus and azole antifungal agents against azole-resistant Candida albicans strains. J Antimicrob Chemother 42 (1998) 747-753
20. Marchetti O., Moreillon P., Glauser M.P., Bille J., and Sanglard D. Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrob Agents Chemother 44 (2000) 2373-2381
21. Edlind T., Smith L., Henry K., Katiyar S., and Nickels J. Antifungal activity in Saccharomyces cerevisiae is modulated by calcium signalling. Mol Microbiol 46 (2002) 257-268
22. Schuetzer-Muehlbauer M., Willinger B., Egner R., Ecker G., and Kuchler K. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast. Int J Antimicrob Agents 22 (2003) 291-300
23. Conseil G., Decottignies A., Jault J.M., et al. Prenyl-flavonoids as potent inhibitors of the Pdr5p multidrug ABC transporter from Saccharomyces cerevisiae. Biochemistry 39 (2000) 6910-6917
24. Niimi K., Harding D.R., Parshot R., et al. Chemosensitization of fluconazole resistance in Saccharomyces cerevisiae and pathogenic fungi by a D-octapeptide derivative. Antimicrob Agents Chemother 48 (2004) 1256-1271
25. Conseil G., Perez-Victoria J.M., Jault J.M., et al. Protein kinase C effectors bind to multidrug ABC transporters and inhibit their activity. Biochemistry 40 (2001) 2564-2571
26. Conseil G., Perez-Victoria J.M., Renoir J.M., Goffeau A., and Di Pietro A. Potent competitive inhibition of drug binding to the Saccharomyces cerevisiae ABC exporter Pdr5p by the hydrophobic estradiol-derivative RU49953. Biochim Biophys Acta 1614 (2003) 131-134
27. Hiraga K., Yamamoto S., Fukuda H., Hamanaka N., and Oda K. Enniatin has a new function as an inhibitor of Pdr5p, one of the ABC transporters in Saccharomyces cerevisiae. Biochem Biophys Res Commun 328 (2005) 1119-1125
28. Yamamoto S., Hiraga K., Abiko A., Hamanaka N., and Oda K. A new function of isonitrile as an inhibitor of the Pdr5p multidrug ABC transporter in Saccharomyces cerevisiae. Biochem Biophys Res Commun 330 (2005) 622-628
29. Simonetti G., Simonetti N., and Villa A. Increase of activity of tioconazole against resistant microorganisms by the addition of butylated hydroxyanisole. Int J Antimicrob Agents 22 (2003) 439-443
30. Kozovska Z., and Subik J. Screening for effectors that modify multidrug resistance in yeast. Int J Antimicrob Agents 22 (2003) 284-290
31. Bissinger K.H., and Kuchler K. Molecular cloning and expression of the Saccharomyces cerevisiae STS1 gene product. A yeast ABC transporter conferring mycotoxin resistance. J Biol Chem 269 (1994) 4180-4186
32. Wu A.L., and Moye-Rowley W.S. GSH1, which encodes gamma-glutamylcysteine synthetase, is a target gene for yAP-1 transcriptional regulation. Mol Cell Biol 14 (1994) 5832-5839
33. Imrichova D., Sarinova M., Cernicka J., Gbelska Y., and Subik J. YAP1 mediated KNQ1 expression in Kluyveromyces lactis. FEMS Yeast Res 5 (2005) 323-329
34. Sojakova M., Liptajova D., Borovsky M., and Subik J. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia. Mycopathologia 157 (2004) 163-169
35. Calabrese D., Bille J., and Sanglard D. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. Microbiology 146 (2000) 2743-2754
36. Wirshing S., Michel S., and Morschhäuser J. Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates. Mol Microbiol 36 (2000) 856-865
37. Franz R., Ruhnke M., and Morschhäuser J. Molecular aspects of fluconazole resistance development in Candida albicans. Mycoses 42 (1999) 453-458
38. Sanglard D., Ischer F., Calabrese D., Majcherczyk P.A., and Bille J. The ATP binding cassette transporter gene Cg CDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents. Antimicrob Agents Chemother 43 (1999) 2753-2765
39. Lorenz R.T., and Parks L.W. Cloning, sequencing, and disruption of the gene encoding sterol C-14 reductase in Saccharomyces cerevisiae. DNA Cell Biol 11 (1992) 685-692
40. Tsai H.F., Bard M., Izumikawa K., et al. Candida glabrata erg1 mutant with increased sensitivity to azoles and to low oxygen tension. Antimicrob Agents Chemother 48 (2004) 2483-2489
41. The use of fused ring-1,2,4-benzotriazine derivatives as herbicides or plant growth regulators for the control of undesired plants or vegetation: compounds, compositions thereof, and processes for their preparation. Bayer Crop GmbH Eur Pat 1502918 A1 2002.
42. Messmer A., Hajos Gy, Benko P., and Pallos L. Condensed as-triazines. VIII. Direct synthesis of 4-substituted triazoles fused to benzo-as-triazine and pyrido[2,3-e]-as-triazine rings. Acta Chim Hung 105 (1980) 189-199
43. Castillo S., Melendez E., Pascual C., and Vilarrasa J. Effects of substituents on the 3-azido-benzo-as-triazine/tetrazolo[5,1-c]benzo-as-triazine/tetrazolo[1,5-b]benzo-as-triazine equilibrium. J Org Chem 47 (1982) 3886
44. Van Den Hazel H.B., Pichler H., Do Valle Matta M., Leitner E., Goffeau A., and Daum G. PDR16 and PDR17, two homologous genes of Saccharomyces cerevisiae, affect lipid biosynthesis and resistance to multiple drugs. J Biol Chem 274 (1999) 1934-1941
45. Mukhopadhyay K., Kohli A., and Prasad R. Drug susceptibilities of yeast cells are affected by membrane lipid composition. Antimicrob Agents Chemother 46 (2002) 3695-3705
46. Lucau-Danila A., Lelandais G., Kozovska Z., et al. Early expression of yeast genes affected by chemical stress. Mol Cell Biol 25 (2005) 1860-1868
47. Bammert G.F., and Fostel J.M. Genome-wide expression patterns in Saccharomyces cerevisiae: comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol. Antimicrob Agents Chemother 44 (2000) 1255-1265
48. De Backer M.D., Ilyina T., Ma X.J., Vandoninck S., Luyten W.H., and Van den Bossche H. Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrob Agents Chemother 45 (2001) 1660-1670
49. Jain P., Akula I., and Edlind T. Cyclic AMP signaling pathway modulates susceptibility of Candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors. Antimicrob Agents Chemother 47 (2003) 3195-3201
50. Loertscher J., Larson L.L., Matson C.K., et al. Endoplasmic reticulum-associated degradation is required for cold adaptation and regulation of sterol biosynthesis in the yeast Saccharomyces cerevisiae. Eukaryot Cell 5 (2006) 712-722